04/30/2008Vicus Therapeutics Records Last Patient Visit of Phase 2 ,VT-122 Trial for the Treatment of Cachexia in Patients with Advanced Lung Cancer ...View press release

03/26/2008Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference ...View press release

12/03/2007Vicus Therapeutics to Present at the BMO Capital Markets Focus on Healthcare Conference ...View press release

10/08/2007Vicus Therapeutics’ Chief Executive Officer to Speak at BIOTECH 2007 on October 8th ...View press release

09/01/2007Repurposing generics for cancer-related conditions ...View press release

08/15/2007Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA ...View press release

06/19/2007Vicus Therapeutics to Present Results from Investigator-led Cancer Cachexia Studies at the 12th Congress of the Japanese Society for Palliative Medicine ...View press release

01/16/2007Vicus Therapeutics Announces FDA Approval of Phase 2 Trial of VT-122 for the Treatment of Cachexia in Patients With Advanced Lung Cancer ...View press release

11/20/2006Vicus Therapeutics to Host Webinar on Repurposing Drugs to Create Proprietary Cancer Products ...View press release

10/16/2006Vicus Therapeutics Signs Strategic Services Agreement with Leading Indian Clinical Research Organization ...View press release